Anula Jayasuriya is of Lineage Cell Therapeutics, Inc.. Currently has a direct ownership of 10,000 shares of LCTX, which is worth approximately $5,000. The most recent transaction as insider was on Dec 29, 2023, when has been sold 10,000 shares (Common Shares, no par value) at a price of $1.09 per share, resulting in proceeds of $10,900. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10K
0% 3M change
n/a 12M change
Total Value Held $5,000

Anula Jayasuriya Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 29 2023
BUY
Open market or private purchase
$10,900 $1.09 p/Share
10,000 Added 50.0%
10,000 Common Shares, no par ...

Also insider at

JAGX
Jaguar Health, Inc. Healthcare
AJ

Anula Jayasuriya

Carlsbad, CA

Track Institutional and Insider Activities on LCTX

Follow Lineage Cell Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LCTX shares.

Notify only if

Insider Trading

Get notified when an Lineage Cell Therapeutics, Inc. insider buys or sells LCTX shares.

Notify only if

News

Receive news related to Lineage Cell Therapeutics, Inc.

Track Activities on LCTX